Statement Regarding Judge’s Approval of Special Master’s Motion to Appoint a Special Investigator

“We support the Court’s approval of the Special Masters’ request as they believe it will assist with ‘the prompt payment of all valid claims.’ As we previously told the Court, a Special Investigator will free up valuable resources so that other claims can be processed more efficiently.” “In less than 18 months, 582 claims totaling […]

September 12, 2018

“We support the Court’s approval of the Special Masters’ request as they believe it will assist with ‘the prompt payment of all valid claims.’ As we previously told the Court, a Special Investigator will free up valuable resources so that other claims can be processed more efficiently.”

“In less than 18 months, 582 claims totaling more than $538 million have been approved — far exceeding the NFL’s estimates of $404 million in the first ten years of the settlement. The evidence is mounting that former players are suffering from neurocognitive ailments at rates even higher than what medical experts previously estimated. We will not allow the NFL to escape this fact and evade its settlement responsibilities by using a small number of potentially fraudulent claims to deny payment to legitimate ones.”

Related News

August 24, 2026
Fifteen Seeger Weiss Attorneys Recognized in the 2027 Edition of The Best Lawyers in America and Ones to Watch

Seeger Weiss is proud to announce that fifteen of our attorneys have been recognized in the 2027 edition of The Best Lawyers in America, including in the Best Lawyers: Ones to Watch in America, and Lawyer of the Year lists. These attorneys have been celebrated for their work in mass tort and class actions, personal […]

Read More
July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More